Oral administration of herbal mixture extract inhibits 2,4-dinitrochlorobenzene-induced atopic dermatitis in BALB/c mice.
Soon Re KimHan-Seok ChoiHye Sook SeoJin Mo KuSe Hyang HongHye-Hyun YooYong Cheol ShinSeong-Gyu KoPublished in: Mediators of inflammation (2014)
CP001 is four traditional herbal medicine mixtures with anti-inflammatory properties. In this study, we investigated the effect of oral administration of CP001 ethanol extract on the 2,4-dinitrochlorobenzene- (DNCB-) induced AD mouse models. For that purpose, we observed the effects of oral administration of CP001 on skin inflammatory cell infiltration, skin mast cells, production of serum IgE, and expression of Th2 cytokine mRNA in the AD skin lesions of DNCB treated BALB/c mice. Histological analyses demonstrated that CP001 decreased dermis and epidermis thickening as well as dermal infiltration induced by inflammatory cells. In addition, CP001 decreased mast cell infiltration in count as well as dermal infiltration induced by inflammatory cells. In the skin lesions, mRNA expression of interleukin- (IL-) 4 and IL-13 was inhibited by CP001. CP001 also reduced the production of IgE level in mouse plasma. In addition, we investigated the effect of CP001 on the inflammatory allergic reaction using human mast cells (HMC-1). In HMC-1, cytokine production and mRNA levels of IL-4, IL-13, IL-6, and IL-8 were suppressed by CP001. Taken together, our results showed that oral administration of CP001 exerts beneficial effects in AD symptoms, suggesting that CP001 might be a useful candidate for the treatment of AD.
Keyphrases
- atopic dermatitis
- oxidative stress
- induced apoptosis
- wound healing
- endothelial cells
- soft tissue
- high glucose
- type diabetes
- adipose tissue
- stem cells
- high resolution
- metabolic syndrome
- cell proliferation
- physical activity
- cell cycle arrest
- insulin resistance
- bone marrow
- drug induced
- mesenchymal stem cells
- cell therapy
- pi k akt